JP2017141225A5 - - Google Patents

Download PDF

Info

Publication number
JP2017141225A5
JP2017141225A5 JP2017025497A JP2017025497A JP2017141225A5 JP 2017141225 A5 JP2017141225 A5 JP 2017141225A5 JP 2017025497 A JP2017025497 A JP 2017025497A JP 2017025497 A JP2017025497 A JP 2017025497A JP 2017141225 A5 JP2017141225 A5 JP 2017141225A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
neuregulin
protein
administered
human subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017025497A
Other languages
English (en)
Japanese (ja)
Other versions
JP6266146B2 (ja
JP2017141225A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017141225A publication Critical patent/JP2017141225A/ja
Publication of JP2017141225A5 publication Critical patent/JP2017141225A5/ja
Application granted granted Critical
Publication of JP6266146B2 publication Critical patent/JP6266146B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017025497A 2009-08-25 2017-02-15 ニューレグリンに基づく心不全の治療方法 Active JP6266146B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23684909P 2009-08-25 2009-08-25
US61/236,849 2009-08-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015192453A Division JP6096262B2 (ja) 2009-08-25 2015-09-30 ニューレグリンに基づく心不全の治療方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017242273A Division JP2018070643A (ja) 2009-08-25 2017-12-19 ニューレグリンに基づく心不全の治療方法

Publications (3)

Publication Number Publication Date
JP2017141225A JP2017141225A (ja) 2017-08-17
JP2017141225A5 true JP2017141225A5 (https=) 2017-09-28
JP6266146B2 JP6266146B2 (ja) 2018-01-24

Family

ID=55360654

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015192453A Active JP6096262B2 (ja) 2009-08-25 2015-09-30 ニューレグリンに基づく心不全の治療方法
JP2017025497A Active JP6266146B2 (ja) 2009-08-25 2017-02-15 ニューレグリンに基づく心不全の治療方法
JP2017242273A Pending JP2018070643A (ja) 2009-08-25 2017-12-19 ニューレグリンに基づく心不全の治療方法
JP2019214810A Pending JP2020050662A (ja) 2009-08-25 2019-11-28 ニューレグリンに基づく心不全の治療方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015192453A Active JP6096262B2 (ja) 2009-08-25 2015-09-30 ニューレグリンに基づく心不全の治療方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017242273A Pending JP2018070643A (ja) 2009-08-25 2017-12-19 ニューレグリンに基づく心不全の治療方法
JP2019214810A Pending JP2020050662A (ja) 2009-08-25 2019-11-28 ニューレグリンに基づく心不全の治療方法

Country Status (2)

Country Link
US (3) US11246909B2 (https=)
JP (4) JP6096262B2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2530526T3 (es) 2005-12-30 2015-03-03 Zensun Shanghai Science And Technology Ltd Liberación extendida de neurregulina para mejorar la función cardíaca
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
AU2012392119B2 (en) 2012-10-08 2018-07-26 Zensun (Shanghai) Science & Technology, Co. Ltd. Compositions and methods for treating heart failure in diabetic patients
EP3895724B1 (en) 2013-05-22 2025-06-25 Zensun (Shanghai) Science and Technology, Co., Ltd. Extended release of neuregulin for treating heart failure
CN110946993A (zh) 2014-01-03 2020-04-03 上海泽生科技开发股份有限公司 纽兰格林制剂的配方
CN111407882A (zh) 2014-10-17 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
CN111407881A (zh) * 2019-01-07 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟心肌损伤的方法和组合物
AR121035A1 (es) 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso
CN117797243A (zh) * 2022-09-30 2024-04-02 上海泽生科技开发股份有限公司 神经调节蛋白及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
AUPP785098A0 (en) 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
CN1138785C (zh) 1999-06-04 2004-02-18 周明东 生长因子神经调节蛋白及其类似物的新应用
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
US20070213264A1 (en) 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
ES2530526T3 (es) 2005-12-30 2015-03-03 Zensun Shanghai Science And Technology Ltd Liberación extendida de neurregulina para mejorar la función cardíaca
CN101394861A (zh) 2005-12-30 2009-03-25 上海泽生科技开发有限公司 纽兰格林持续给药能改善心脏功能
US9580515B2 (en) 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
US20090156488A1 (en) 2007-09-12 2009-06-18 Zensun (Shanghai) Science & Technology Limited Use of neuregulin for organ preservation
EP2370093A4 (en) 2008-11-28 2012-08-29 Zensun Shanghai Science And Technology Ltd NEUREGULIN AND CARDIAC STEM CELLS
EP2370458B1 (en) 2008-11-28 2014-10-15 Zensun (Shanghai) Science and Technology Limited Neuregulin peptides and their use
ES2748886T3 (es) 2009-06-09 2020-03-18 Zensun Shanghai Science & Tech Co Ltd Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
ES2575125T3 (es) 2009-06-09 2016-06-24 Zensun (Shanghai) Science And Technology Limited Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
CN102139095A (zh) 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
EP3895724B1 (en) 2013-05-22 2025-06-25 Zensun (Shanghai) Science and Technology, Co., Ltd. Extended release of neuregulin for treating heart failure
CN110946993A (zh) 2014-01-03 2020-04-03 上海泽生科技开发股份有限公司 纽兰格林制剂的配方
CN105497876B (zh) 2014-09-24 2021-01-15 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
CN111407882A (zh) 2014-10-17 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物

Similar Documents

Publication Publication Date Title
JP2017141225A5 (https=)
JP2013503110A5 (https=)
JP2019510739A5 (https=)
JP2015517489A5 (https=)
JP2017532343A5 (https=)
JP2017113019A5 (https=)
JP2023082054A5 (https=)
JP2011157378A5 (https=)
JP2012126742A5 (https=)
PH12019502033A1 (en) Pharmaceutical composition comprising selexipag
JP2014508748A5 (https=)
JP2018198596A5 (https=)
EP4570264A3 (en) Vaccine against porcine parvovirus
JP2009531283A5 (https=)
JP2016512425A5 (https=)
JP2013539454A5 (https=)
JP2016539089A5 (https=)
JPWO2019107530A5 (https=)
JP2016520075A5 (https=)
CN113366016A (zh) 抗人白细胞介素5(il-5)单克隆抗体及其应用
JP2019509054A5 (https=)
JP2006506942A5 (https=)
JP2019214579A5 (https=)
JP2017039729A5 (https=)
BR112021020883A2 (pt) Formas sólidas de um inibidor de glyt1